At­trac­tive M&A op­tions? An­a­lysts break down what's hot right now

With the num­ber of bio­phar­ma ac­qui­si­tions in 2022 so far falling be­low re­cent years, the in­vest­ment bank SVB Se­cu­ri­ties on Sun­day pub­lished a new re­port …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA